Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

CK2A1 S2110-p , T2159-p
PKACA T2159-p
Treatment:
antibody T2328-p
AZD1152 S2138-p
colforsin T2159-p
dasatinib S2102-p
EGF S2138-p
gefitinib Y2249-p
H-89 T2159-p
ischemia S2169-p , T2328-p , S2358-p
LPA T2320-p
LRRK2-IN-1 S2358-p
metastatic potential S2138-p
nocodazole S163-p , S228-p , S817-p , S825-p , S1057-p , T1216-p , T1217-p , S2138-p , S2169-p , T2320-p , S2340-p , S2341-p
selumetinib T1216-p , T1217-p , T2328-p
Su11274 Y2039-p
U0126 Y777-p
vemurafenib T1216-p , T1217-p , S2319-p , T2320-p , T2328-p
vorinostat K497-ac , K1809-ac , K1815-ac , K1913-ac
ZM447439 S2138-p